Basmisanil

DRUG4 trials

Sponsors

Hoffmann-La Roche

Conditions

Dup15q SyndromeHealthy VolunteerSchizophreniaStroke

Phase 1

Basmisanil Positron Emission Tomography Study in Japanese Volunteers

CompletedNCT02534207

Hoffmann-La RocheHealthy Volunteer

Start: 2015-08-31End: 2015-11-30Updated: 2017-01-26

Phase 2

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

TerminatedNCT02928393

Hoffmann-La RocheStroke

Start: 2017-02-20End: 2017-11-03Updated: 2019-01-02

A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

CompletedNCT02953639

Hoffmann-La RocheSchizophrenia

Start: 2016-11-30End: 2019-12-12Updated: 2021-02-09

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

TerminatedNCT05307679

Hoffmann-La RocheDup15q Syndrome

Start: 2022-12-16End: 2024-03-04Updated: 2026-08-18

Related Papers

A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia.

2026-04-15